Caissa Capital Management ltd. - 26 Jun 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Issuer symbol
AVTX
Transactions as of
26 Jun 2023
Net transactions value
-$1,030,179
Form type
4
Filing time
27 Jun 2023, 16:10:55 UTC
Previous filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $917,153 -1,425,700 -100% $0.6433 0 26 Jun 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $113,026 -182,300 -100% $0.6200 0 26 Jun 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Caissa Capital Management ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.45 to $0.84, inclusive.
F3 These shares are directly owned by Mr. Golestaneh in his personal capacity.